Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Berkley Renewables Inc.

Market Cap 364K 315K 290K 271K 509K 34.64M 517K 3.42M 1.34M 16.86M 1.37M 1.34M 58.37M P/E Ratio 2016
4.22x
P/E Ratio 2017 -1.16x
Enterprise Value 5.13M 4.43M 4.08M 3.82M 7.16M 487M 7.27M 48.17M 18.78M 237M 19.24M 18.83M 821M EV / Sales 2016
3.53x
EV / Sales 2017 3.18x
Free-Float
90.7%
Yield 2016 *
-
Yield 2017 -
10 years 0.02
Extreme 0.015
0.15
Manager TitleAgeSince
Chief Executive Officer 63 19/06/2002
Director of Finance/CFO - -
Director TitleAgeSince
Chairman 63 -
Director/Board Member 66 16/08/2006
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-.--% 459K
+0.81%-6.10%+33.26%+120.92% 156B
+1.40%-0.14%+20.65%+13.12% 143B
-0.19%-0.56%+38.13%+69.79% 94.47B
+0.09%-0.82%+9.08%+21.23% 72.78B
+1.93%-0.69%+21.72%-3.79% 56.24B
+0.28%-0.25%+24.03%+47.72% 54.05B
-0.80%+0.15%+95.78%+74.72% 52.91B
+1.57%+2.33%+29.05%-10.08% 52.26B
-0.92%+1.04%+23.88%-8.87% 41.88B
Average +0.42%-0.98%+29.56%+32.48% 72.35B
Weighted average by Cap. +0.61%-1.70%+31.12%+47.47%

Financials

2016 2017
Net sales 1.03M 893K 823K 770K 1.44M 98.29M 1.47M 9.72M 3.79M 47.84M 3.88M 3.8M 166M 1.72M 1.49M 1.37M 1.28M 2.41M 164M 2.45M 16.21M 6.32M 79.8M 6.47M 6.34M 276M
Net income 173K 149K 137K 129K 241K 16.42M 245K 1.62M 633K 7.99M 648K 634K 27.67M -631K -545K -502K -470K -880K -59.93M -894K -5.93M -2.31M -29.17M -2.37M -2.32M -101M
Net Debt 2.92M 2.52M 2.32M 2.17M 4.07M 277M 4.14M 27.41M 10.69M 135M 10.95M 10.71M 467M 4.76M 4.11M 3.79M 3.55M 6.65M 453M 6.75M 44.74M 17.45M 220M 17.87M 17.49M 763M
Logo Berkley Renewables Inc.
Berkley Renewables Inc. is a Canada-based, growth-oriented diversified issuer also pursuing renewable energy opportunities, primarily in the solar energy sector. The Company is pursuing solar energy investments in Ontario, Canada. It is also engaged in developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function through RepliCel Life Sciences Inc. The Company's RCT-01, RCS-01, and RCH-01 cell therapies are designed to treat chronic tendinosis, damaged or aged skin and pattern baldness. The Company is also developing a proprietary injection device (RCI) for optimal clinical delivery. The Company is developing solar photovoltaic (PV) projects in Ontario, Canada, through its subsidiary, Solar Flow-Through General Partnership. Working with Solar Flow-Through, the Company has also developed a flow-through investment vehicle for investors to participate in Ontario's solar energy growth.
Employees
-
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!